PRESS RELEASE published on 01/16/2026 at 00:00, 4 months 25 days ago LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies LIR Life Sciences Corp. announces a controlled comparative animal study to evaluate needle-free transdermal delivery of GLP/GIP-based obesity therapies. Study aims to advance transdermal platform and simplify treatment for obesity Lir Life Sciences Corp. Obesity Therapies GLP/GIP-based Controlled Study Needle-free Transdermal Delivery
BRIEF published on 01/09/2026 at 00:05, 5 months 1 day ago LIR Life Sciences collabore avec Neuland Labs au développement de peptides LIR Sciences De La Vie Laboratoires Neuland Peptides Pénétrant Dans Les Cellules Plateforme Transdermique Collaboration En R&D
BRIEF published on 01/09/2026 at 00:05, 5 months 1 day ago LIR Life Sciences Collaborates with Neuland Labs on Peptide Development R&D Collaboration LIR Life Sciences Neuland Laboratories Cell Penetrating Peptides Transdermal Platform
PRESS RELEASE published on 01/09/2026 at 00:00, 5 months 1 day ago LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform LIR Life Sciences Corp. enters R&D Agreement with Neuland Labs for peptide formulations. Neuland Labs to provide services for preclinical evaluation and future collaboration Lir Life Sciences Corp. Neuland Labs R&D Agreement Peptide Formulations Preclinical Evaluation
BRIEF published on 12/19/2025 at 00:05, 5 months 22 days ago LIR Life Sciences nomme le Dr Peter Singer au poste de conseiller scientifique Innovation En Santé Traitement De L'obésité LIR Sciences De La Vie Peter Singer Conseiller Scientifique
BRIEF published on 12/19/2025 at 00:05, 5 months 22 days ago LIR Life Sciences Appoints Dr. Peter Singer as Scientific Advisor Obesity Treatment Health Innovation LIR Life Sciences Scientific Advisor Peter Singer
PRESS RELEASE published on 12/19/2025 at 00:00, 5 months 22 days ago LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor LIR Life Sciences Corp. announces Dr. Peter Singer, former WHO advisor, as Scientific Advisor. Focus on global obesity treatments & market making services Market Making Services Lir Life Sciences Corp. Obesity Treatments Scientific Advisor Dr. Peter Singer
BRIEF published on 12/12/2025 at 00:05, 5 months 29 days ago LIR Life Sciences développe des traitements contre l'obésité sans aiguilles Traitement De L'obésité Brevet Provisoire Accouchement Sans Aiguille Thérapies GLP/GIP LIR Sciences De La Vie
BRIEF published on 12/12/2025 at 00:05, 5 months 29 days ago LIR Life Sciences Pursues Needle-Free Obesity Therapy Delivery Obesity Treatment Provisional Patent Needle-free Delivery GLP/GIP Therapies LIR Life Sciences
PRESS RELEASE published on 12/12/2025 at 00:00, 5 months 29 days ago LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies LIR Life Sciences files provisional patent for needle-free delivery platform for GLP/GIP therapies in obesity and metabolic diseases, aiming to improve treatment accessibility and adherence Metabolic Diseases Obesity Provisional Patent GLP/GIP Therapies LIR Life Sciences
Published on 06/10/2026 at 14:30, 7 hours 47 minutes ago Agassi Sports Entertainment Signs Tennis Coaching Icon Darren Cahill to Expand Global Coaching, Content and Technology Initiatives
Published on 06/10/2026 at 14:30, 7 hours 47 minutes ago Ondas to Launch LADOS, a Layered Autonomous Defense Operational C2 Layer, at Eurosatory 2026
Published on 06/10/2026 at 13:00, 9 hours 17 minutes ago Galway Metals Reports 5.0 g/t Gold over 10.85 Metres at North Deposit and Continues to Intersect Gold in Northern Extension
Published on 06/10/2026 at 13:00, 9 hours 17 minutes ago Jaguar Mining Inc. Accelerates 5-Year Exploration Plan with Tier 1 Drilling Partnerships
Published on 06/10/2026 at 22:05, 12 minutes ago Ridgewood Infrastructure Acquires Dauntless Air, Premier Provider of Emergency Management Infrastructure
Published on 06/10/2026 at 21:45, 32 minutes ago EQS-Adhoc: MAHLE has successfully priced the issuance of additional EUR 200 million notes due 2032 and is launching a partial tender offer for its outstanding notes due 2028
Published on 06/10/2026 at 20:11, 2 hours 6 minutes ago EQS-Adhoc: EDAG Engineering Group AG: Board of Directors resolves on capital measures to strengthen capital base
Published on 06/10/2026 at 18:39, 3 hours 38 minutes ago EQS-Adhoc: Kontron AG: Ad hoc announcement / Ennoconn Corporation intends to launch a mandatory takeover offer to Kontron AG shareholders
Published on 06/10/2026 at 18:20, 3 hours 57 minutes ago EQS-WpÜG: Takeover Offer / Target company: Hugo Boss AG; Bidder: Frasers Group plc
Published on 06/10/2026 at 19:00, 3 hours 17 minutes ago ALTAREA - Répartition fiscale du dividende 2025 (adopté par l'assemblée générale mixte du 4 juin 2026)
Published on 06/10/2026 at 18:29, 3 hours 48 minutes ago ICADE – PR – OUTCOME OF THE COMBINED GENERAL MEETING HELD ON JUNE 10 2026
Published on 06/10/2026 at 18:29, 3 hours 48 minutes ago ICADE – CP – COMPTE-RENDU DE L’ASSEMBLEE GENERALE MIXTE DU 10 JUIN 2026
Published on 06/10/2026 at 18:26, 3 hours 51 minutes ago ICADE – CP – DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS